
Kornique Pharmaceuticals Private Limited
About Kornique Pharmaceuticals Private Limited
Data last updated:
Kornique Pharmaceuticals Private Limited is a private limited company based in Kosikalan, Uttar Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 17 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85191UP2015PTC069596.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santoshkumar and Hari Ram Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Near Sri Ji Guest House Kamala Nagar Kosi Kosikalan, Uttar Pradesh, India – 281403.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.68 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹56,826 (net margin -3%) and EBITDA of -₹56,826 (EBITDA margin -3%). Revenue has grown at a compounded annual rate (CAGR) of 42% over three years and 32% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Kornique Pharmaceuticals Private Limited's registered office is in Kosikalan, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNear Sri Ji Guest House Kamala Nagar Kosi Kosikalan, Uttar Pradesh, India – 281403
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Kornique Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kornique Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Kornique Pharmaceuticals Private Limited, buy the company report.
Financials of Kornique Pharmaceuticals Private Limited
FY 2024 filings availableKornique Pharmaceuticals Private Limited reported revenue of ₹18.68 Lakh (up 219% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 219% growth in the latest year. EBITDA rose 89% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹56,826 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹56,826 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -3% | ||||
| Net Profit Margin | -3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kornique Pharmaceuticals Private Limited, buy the company report.
Board of directors of Kornique Pharmaceuticals Private Limited
Kornique Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santoshkumar | Director | 20 Aug 2016 | 10 Years 2 Months | Current |
| Hari Ram Sharma | Director | 17 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Kornique Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| DMPL Pharmaceuticals Private Limited | ₹18.9 Lakh (FY 2020) | 432.0% | Dombivali Thane, Maharashtra, India | |||
| Kornique Pharmaceuticals Private Limitedthis company | ₹18.68 Lakh (FY 2024) | -₹56,826 | -3% | 219.0% | Kosikalan, Uttar Pradesh, India | |
| Sykus Pharmaceuticals Private Limited | ₹18.62 Lakh (FY 2025) | -10.0% | Ambala, Haryana, India | |||
| Fosen Pharmaceuticals Private Limited | ₹18.61 Lakh (FY 2025) | 482.0% | Cuttack, Odisha, India |
To see the full peer comparison of Kornique Pharmaceuticals Private Limited, buy the company report.
Auditor
Kornique Pharmaceuticals Private Limited is audited by Garg Arun & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Garg Arun & Associates | FY 2017 | 08180N |
Shareholding
The shareholding of Kornique Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Kornique Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Kornique Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kornique Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kornique Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kornique Pharmaceuticals Private Limited has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Rakesh Kumar ceased to be Director on 18 Jul 2017.
Frequently asked questions
Kornique Pharmaceuticals is an active private limited company based in Kosikalan, Uttar Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 17 March 2015 (11+ years old) and is registered under CIN U85191UP2015PTC069596.
Kornique Pharmaceuticals has 2 current directors:
- Santoshkumar - Director
- Hari Ram Sharma - Director
The latest financial statements of Kornique Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Kornique Pharmaceuticals is U85191UP2015PTC069596. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kornique Pharmaceuticals was incorporated on 17 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Kornique Pharmaceuticals by revenue are DMPL Pharmaceuticals Private Limited, Sykus Pharmaceuticals Private Limited, Fosen Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Rakesh Kumar ceased to be Director on 18 Jul 2017. Santoshkumar was appointed as Director on 20 Aug 2016. Hari Ram Sharma was appointed as Director on 17 Mar 2015.
The registered office of Kornique Pharmaceuticals is at Near Sri Ji Guest House Kamala Nagar Kosi Kosikalan, Uttar Pradesh, India – 281403.
Kornique Pharmaceuticals operates in the chemicals industry, in the chemical products segment.
The compliance status of Kornique Pharmaceuticals is compliant as of 24 August 2026. The company is actively filing with the Registrar of Companies.
Kornique Pharmaceuticals can be reached at its registered office: Near Sri Ji Guest House Kamala Nagar Kosi Kosikalan, Uttar Pradesh, India – 281403.

